Bruker’s (NASDAQ:BRKR) Q4 CY2025 Sales Beat Estimates
Q4-25 revenues of $977.2 million, flat year-over-year (yoy), down ~5% organically Q4-25 GAAP diluted earnings per share (EPS) of $0.10; non-GAAP diluted...
At SLAS2026 , Chemspeed Technologies , a leader in the automation and digitalization of R&D and QC laboratories, and SciY , a leader in scientific and laboratory...
New iNTApharma system enables rapid, native‑state size and concentration measurements with single‑particle sensitivity for viral, vesicle, and nanoscale bioparticle workflows
Bruker Corporation (Nasdaq: BRKR, BRKRP) today announced that its Board of Directors (“Board”) has approved payment of a quarterly cash dividend in the amount of $3.9844 per share on the Company’s...
Bruker Corporation (Nasdaq: BRKR) today announced it will report fourth quarter and fiscal year 2025 financial results before market opening on Thursday, February 12, 2026. The Company will host...
1 Healthcare Stock Worth Investigating and 2 That Underwhelm